Vertex isn't just a rare disease company

Cystic fibrosis may be Vertex Pharmaceuticals’ commercial bread and butter, but the drugmaker shouldn’t be pigeonholed as a rare disease company, executives said on a call with analysts Thursday. T

Related Keywords

,Vertex Pharmaceuticals ,Reshma Kewalramani ,Cystic Fibrosis ,Rare Diseases ,Rikafta Elexacaftor Ivacaftor Tezacaftor ,Earnings ,Main Drugs ,Sickle Cell Disease ,Beta Thalassemia ,Fierce Pharma Homepage ,Pharma ,